Kim MS - Search Results

1

The contemporary management of cancers of the sinonasal tract in adults.

Thawani R, Kim MS, Arastu A, Feng Z, West MT, Taflin NF, Thein KZ, Li R, Geltzeiler M, Lee N, Fuller CD, Grandis JR, Floudas CS, Heinrich MC, Hanna E, Chandra RA. Thawani R, et al. Among authors: kim ms. CA Cancer J Clin. 2023 Jan;73(1):72-112. doi: 10.3322/caac.21752. Epub 2022 Aug 2. CA Cancer J Clin. 2023. PMID: 35916666 Free PMC article. Review.

2

Addressing Sex Disparities in Academic Oncology: What Can We Do?

Jenei K, West MT, Kim MS. Jenei K, et al. Among authors: kim ms. JAMA Oncol. 2022 Jun 1;8(6):819-820. doi: 10.1001/jamaoncol.2022.0165. JAMA Oncol. 2022. PMID: 35420635 No abstract available.

3

Paraganglioma of the Head and Neck: A Review.

Sandow L, Thawani R, Kim MS, Heinrich MC. Sandow L, et al. Among authors: kim ms. Endocr Pract. 2023 Feb;29(2):141-147. doi: 10.1016/j.eprac.2022.10.002. Epub 2022 Oct 15. Endocr Pract. 2023. PMID: 36252779 Free PMC article. Review.

4

US Food and Drug Administration approvals for Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukemia: Potential inefficiencies in trial design and evidence generation.

Kim MS, Prasad V. Kim MS, et al. Cancer. 2020 Oct 1;126(19):4270-4272. doi: 10.1002/cncr.33058. Epub 2020 Jul 9. Cancer. 2020. PMID: 32644193 Free article.

5

Quality of biomarker defined subgroups in FDA approvals of PD-1/PD-L1 inhibitors 2014 to 2020.

Kim MS, Xu A, Haslam A, Prasad V. Kim MS, et al. Int J Cancer. 2022 Jun 1;150(11):1905-1910. doi: 10.1002/ijc.33968. Epub 2022 Feb 26. Int J Cancer. 2022. PMID: 35182072 Free article.

6

Artificial intelligence and magnetic resonance imaging may not make cancer screening better.

Powell K, Kim MS, Haslam A, Prasad V. Powell K, et al. Among authors: kim ms. J Cancer Policy. 2022 Mar;31:100314. doi: 10.1016/j.jcpo.2021.100314. Epub 2021 Nov 27. J Cancer Policy. 2022. PMID: 35559866 No abstract available.

7

Comparison of Classification of Indications for Allogeneic and Autologous Transplant for Adults in ASTCT Guidelines and Evidence Available in Published Literature.

Kim MS, Cai J, Maniar A, Kartika T, Haslam A, Prasad V. Kim MS, et al. JAMA Intern Med. 2022 Jan 1;182(1):76-78. doi: 10.1001/jamainternmed.2021.4826. JAMA Intern Med. 2022. PMID: 34491275 Free PMC article. Review.

8

Pembrolizumab for all.

Kim MS, Prasad V. Kim MS, et al. J Cancer Res Clin Oncol. 2023 Mar;149(3):1357-1360. doi: 10.1007/s00432-022-04412-4. Epub 2022 Oct 22. J Cancer Res Clin Oncol. 2023. PMID: 36271954 Free PMC article.

9

Approval and Coverage of Cancer Drugs in England, Canada, and the US.

Prasad V, Kim MS. Prasad V, et al. Among authors: kim ms. JAMA Intern Med. 2021 Apr 1;181(4):509-510. doi: 10.1001/jamainternmed.2020.8587. JAMA Intern Med. 2021. PMID: 33616600 No abstract available.

10

A phase II study of obinutuzumab in combination with ibrutinib for treatment of relapsed mantle cell lymphoma.

Kim MS, Banerjee T, Chen A, Danilov A, MacKinnon R, Thurlow B, Thakurta S, Orand K, Degnin C, Park B, Spurgeon SE. Kim MS, et al. Leuk Lymphoma. 2023 Mar;64(3):722-724. doi: 10.1080/10428194.2022.2045598. Epub 2022 Mar 9. Leuk Lymphoma. 2023. PMID: 35263204 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,790 results

Search Page